Publication | Closed Access

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

OncologyAdjuvant ChemotherapyPathologyImmune Checkpoint InhibitorCancer TreatmentMedicineRadiation OncologyAdjuvant AtezolizumabLung Cancer